Anthropic is moving from selling AI tools to drugmakers to trying to develop drugs itself.

At its "AI for Science" event, the company announced Claude Science, an AI workbench for scientists that brings fragmented tools and datasets into one environment and can generate figures and visuals.

Then it went further: Anthropic says it plans to discover treatments for neglected diseases.

The plan is heading in the same direction that OpenAI set out on some time ago: fully autonomous researchers focused in particular on drug discovery. A revenue field of as yet unimaginable scale, especially if longevity truly gains momentum.

Anthropic wants to be at the forefront. Via The Verge